Banner - NPPA Connect

|Poll|September 26, 2022

POLL: How Many People in the US Have Generalized Pustular Psoriasis?

Author(s)Dermatology Times Staff

Click here to answer this week's poll.

How many people in the US have generalized pustular psoriasis?

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

FDA Accepts Bezuclastinib NDA for Advanced Systemic Mastocytosis

ByKaitlyn Bader, Assistant Managing Editor

September 15th 2026

Q&A: Victoria Werth, MD, on Brepocitinib's FDA Approval for Dermatomyositis

ByVictoria Werth, MD,Kaitlyn Bader, Assistant Managing Editor

September 15th 2026

Prevention and Early Detection Take Center Stage at NP/PA Connect Cutaneous Oncology Workshop

ByTristan Hasbargen, PA-C,Amit Om, MD,Amy Spizuoco, DO, FAOCD,Shannon Heaning, Content Associate

September 12th 2026

FDA Grants QRX003 Rare Pediatric Disease Designation in Peeling Skin Syndrome

ByShannon Heaning, Content Associate

September 8th 2026

QRX003 Meets Primary Endpoint in Netherton Syndrome Trial

ByShannon Heaning, Content Associate

August 28th 2026

Latest CME

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Trending on Dermatology Times

FDA Grants Priority Review to Zasocitinib for Moderate-to-Severe Plaque Psoriasis

FDA Accepts Bezuclastinib NDA for Advanced Systemic Mastocytosis

Genetic Study Links Higher BMI to Perceived Facial Aging, but Causality Remains Unproven

Defining AD Disease Flares vs Drug Effects: A Comparative Analysis of Phase 3 Systemic Therapy Trials

FDA Approves Ameluz Red Light PDT for Superficial Basal Cell Carcinoma